Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

298 evidences · page 5 / 12

34,6 %34.6% of the 231 women cited invasion of privacy by male doctors as a reason for avoiding cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

7 %VIA positivity was 7% among women living with HIV (WLHIV).

Nigeriacancer du col de l'utérusobservé 2021publié 2023BMC public healthPubMeddocument de 12 observations

94 %Among 400 female students in tertiary institutions in Imo State, 376 (94%) cited embarrassment as the most prevalent reason for not undertaking cervical screening.

Nigeriacancer du col de l'utéruspublié 2021Journal of community healthPubMeddocument de 9 observations

9 %Uptake of cervical cancer screening among mothers of female secondary school students in Abakaliki was 9%.

Nigeriacancer du col de l'utéruspublié 2019Nigerian journal of clinical practicePubMeddocument de 7 observations

50 %The most common stage at presentation was FIGO Stage IIB in 50% of patients.

Nigeriacancer du col de l'utéruspublié 2025BrachytherapyPubMeddocument de 8 observations

Cervical cancer is the second most common cancer in women globally.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

73,2 %73.2% of the female postgraduate students at the University of Ibadan preferred female doctors to conduct cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 6 observations

7 %Cervical cancer screening rates were 7 to 25% in other West African countries.

Nigeriacancer du col de l'utéruspublié 2026BMC public healthPubMeddocument de 3 observations

34,6 %Comprehensive knowledge of cervical cancer was low (34.6%) among women of reproductive age living with HIV in North Central Nigeria.

Nigeriacancer du col de l'utéruspublié 2025The Pan African medical journalPubMeddocument de 4 observations

0,6 %Uptake of pap smear was 0.6% in the control group at baseline.

Nigeriacancer du col de l'utéruspublié 2022BMC women's healthPubMeddocument de 5 observations

10 %10% of respondents were aware of the human papillomavirus vaccine for the prevention of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021JCO global oncologyPubMeddocument de 7 observations

9 %Only 9.0% of the female secondary school teachers in Enugu metropolis had a programme in their school that addresses cervical cancer or cervical cancer vaccination.

Nigeriacancer du col de l'utérusobservé 2017publié 2021The Pan African medical journalPubMeddocument de 7 observations

61,5 %Among 991 women of reproductive age living with HIV in North Central Nigeria, 61.5% had never been screened for cervical cancer.

Nigeriacancer du col de l'utéruspublié 2025The Pan African medical journalPubMeddocument de 4 observations

4 %4% of respondents had been screened with the Papanicolaou test.

Nigeriacancer du col de l'utéruspublié 2021JCO global oncologyPubMeddocument de 7 observations

42,7 %Less than half of the respondents had good knowledge of cervical cancer (42.7%).

Nigeriacancer du col de l'utérusobservé April 2021publié 2024The Pan African medical journalPubMeddocument de 8 observations

Cervical cancer is the second most frequent cancer among women in Nigeria.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

Cervical cancer is the second leading cause of cancer incidence and mortality among Nigerian women.

Nigeriacancer du col de l'utérusPubMeddocument de 7 observations

48,1 %48.1% of the participants noted that HPV can cause cervical cancer.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2024BMC public healthPubMeddocument de 12 observations

8 685 Instagram accountsSix finalist entries were shared on social media to promote cervical cancer awareness, reaching 8685 individual Instagram accounts and generating 2727 likes and 782 comments.

Nigeriacancer du col de l'utéruspublié 2026JMIR formative researchPubMeddocument de 7 observations

40,9 %40.9% of the women cited lack of knowledge of the importance of being screened for cervical cancer as a reason for not being screened.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

11,1 %11.1% of rural women in North Central Nigeria cited low perceived susceptibility as a barrier to cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

Cervical cancer is the major cause of cancer deaths in developing countries.

Nigeriacancer du col de l'utéruspublié 2021Journal of preventive medicine and hygienePubMeddocument de 11 observations

242 patientsAmong 343 cervical cancer patients, 242 (70.55%) had stage II or III disease.

Nigeriacancer du col de l'utérusobservé March 2021 to June 2024PubMeddocument de 6 observations

58,1 %58.1% of the study participants had high-grade squamous intraepithelial lesion or invasive cervical cancer (HSIL/ICC).

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesionobservé 2020–2022publié 2023BMC cancerPubMeddocument de 14 observations

57,82 yearsThe average age of 343 cervical cancer patients was 57.82 ± 11.77 years.

Nigeriacancer du col de l'utérusobservé March 2021 to June 2024PubMeddocument de 6 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.